TREATMENT OF UREA CYCLE DISORDERS IN NEONATES AND INFANTS

• 收藏
• 分享

专利权人:

Horizon Therapeutics; LLC

发明人:

Bruce SCHARSCHMIDT,Masoud MOKHTARANI

申请号：

US15684876

公开号：

US20170348269A1

申请日:

2017.08.23

申请国别(地区):

US

年份:

2017

代理人:

摘要：

Nitrogen scavenging drugs such as glycerol phenylbutyrate can be administered safely to infants and toddlers with urea cycle disorders by adjusting the dosage based on one or more biomarkers selected from the group consisting of urinary-PAGN and plasma PAA:PAGN ratio.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/